Atlas Trials

A Phase I/II Study of Ganetespib in Combination With Doxorubicin

Clinical trial NCT02261805 · TERMINATED

Trial details

NCT number
NCT02261805
Sponsor
Georgetown University
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
CancerSmall Cell Lung Cancer
Start date
2014-10-01
Primary completion
2016-10-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.